Neos Therapeutics Statement: COVID-19 Update
DALLAS and FORT WORTH, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Jerry McLaughlin, President and CEO, made the following statement:We […]
DALLAS and FORT WORTH, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Jerry McLaughlin, President and CEO, made the following statement:We […]
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing […]
Soticlestat continues to appear to be safe and well-tolerated; the majority of the 11 patients showed a reduction in seizuresAll […]
TALLAHASSEE, Fla., March 30, 2020 (GLOBE NEWSWIRE) — Capital City Bank Group (NASDAQ: CCBG) announced today that, due to the […]
SAN DIEGO, March 30, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported […]
SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused […]
– Kalbe Genexine Biologics (“KG Bio”) will receive right of first negotiation for an exclusive license to potentially commercialize I-Mab’s […]
AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) — Chuy’s Holdings, Inc. (NASDAQ:CHUY) today provided a business update in light of […]
Hunter Smith, Chief Financial Officer, appointed Interim Chief Executive Officer following completion of NDA submission to FDA Precautionary measures in place […]
– Potential to be First Superior Therapy to Standard of Care for Chemotherapy-Induced Neutropenia in 30 Years –– Targeting CIN […]